Aβ40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's Disease

• Carol Man Gao ,

  Contributed equally to this work with: Carol Man Gao, Alice Y. Yam

  Affiliation Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

  ⨯
• Alice Y. Yam ,

  Contributed equally to this work with: Carol Man Gao, Alice Y. Yam

  Affiliation Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

  ⨯
• Xuemei Wang,

  Affiliation Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

  ⨯
• Erika Magdangal,

  Affiliation Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

  ⨯
• Cleo Salisbury,

  Affiliation Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

  ⨯
• David Peretz,

  Affiliation Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

  ⨯
• Ronald N. Zuckermann,

  Current address: Lawrence Berkeley National Laboratory, Molecular Foundry, Berkeley, California, United States of America

  Affiliation Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

  ⨯
• Michael D. Connolly,

  Current address: Lawrence Berkeley National Laboratory, Molecular Foundry, Berkeley, California, United States of America

  Affiliation Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

  ⨯
• Oskar Hansson,

  Affiliation Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden

  ⨯
• Lennart Minthon,

  Affiliation Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden

  ⨯
• Henrik Zetterberg,

  Affiliation Clinical Neurochemistry Laboratory, Department of Neuroscience and Physiology, Sahlgrenska University Hospital, Mölndal, Sweden

  ⨯
• Kaj Blennow,

  Affiliation Clinical Neurochemistry Laboratory, Department of Neuroscience and Physiology, Sahlgrenska University Hospital, Mölndal, Sweden

  ⨯
• Joseph P. Fedynyshyn ,

  * E-mail: joseph.fedynyshyn@novartis.com

  Affiliation Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

  ⨯
• Sophie Allauzen

  Affiliation Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

  ⨯